JULIE MCCARDELL: Open Payments
NPI 1255312989 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,901 in 98 payments from 17 companies in 2025. Trend: 2023 $2,309 · 2024 $4,573 · 2025 $1,901
Food & beverage: $1,793Education: $109
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 22 | $447 |
| Janssen Biotech, Inc. | 21 | $327 |
| ABBVIE INC. | 20 | $246 |
| Janssen Scientific Affairs, LLC | 1 | $133 |
| Lilly USA, LLC | 5 | $121 |
| Galderma Laboratories, L.P. | 5 | $98 |
| Novartis Pharmaceuticals Corporation | 4 | $85 |
| GENZYME CORPORATION | 1 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $65 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
Products named: TREMFYA, Bimzelx, SKYRIZI, RINVOQ, DUPIXENT, EBGLYSS, COSENTYX, NEMLUVIO.
Industry payments across ID — which companies pay providers there.
